<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Making medicines evergreen

descriptionPublicationkeyboard_double_arrow_right Article 29 Nov 2012 English Publisher:BMJJournal:BMJ, volume 345, pages e7941-e7941 (eissn: 1756-1833,

Authors: Teck K Khong; Andrew W. Hitchings; Emma H. Baker;

doi: 10.1136/bmj.e7941

pmid: 23197598

Making medicines evergreen

- Summary
- Subjects
- Metrics

Abstract

Andrew Hitchings, Emma Baker, and Teck Khong examine how drug companies maximise profits after patents expire and show why regulatory agencies, policy makers, and prescribers need to be alert to the use of these techniques

Related Organizations

University of London
United Kingdom
St George's, University of London
United Kingdom

Keywords

Drug Industry, Drugs, Generic, Humans, Drug Prescriptions, Drug Costs, United Kingdom

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	32
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%